• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A new process for the preparation of 6-deoxyanthracyclinones of general formula I: <IMAGE> I wherein R represents a hydrogen atom, a hydroxy group or a lower alkoxy group is described. The process provides a total synthesis of the 6-deoxyanthracyclinones of formula I using 1,2,3,6-tetrahydro-phthalate as starting material. The obtained racemic mixture of the compounds of formula I, if desired, can be submitted to optical resolution by the conventional method of conversion to diastereomeric derivatives using a chiral resolving agent. Alternatively, the racemic mixture can be used as such for the condensation with a suitably protected halosugar derivative to obtain alpha glycosidic derivatives of formula XV: <IMAGE> XV wherein R1 represents a hydrogen atom or a hydroxy group, one of R2 and R3 represents a hydrogen atom, the other of R2 and R3 represents a hydrogen atom or a hydroxy group and X is a hydrogen atom or a trifluoro acetyl group. The N-trifluoroacetyl 7S:9S and 7R:9R derivatives of the alpha -glycosides of formula XV can be separated by chromatography on silica gel to obtain, after mild alkaline hydrolisis the wanted 7S:9S alpha -glycosides (R1=H) as free bases and can eventually be transformed into their corresponding doxorubicin derivatives (R1=OH) by known procedures.
    公开号:SU1429935A3
    申请号:SU843823254
    申请日:1984-12-13
    公开日:1988-10-07
    发明作者:Анджелуччи Франческо；Пенко Сердж；Ванотти Эрмес；Аркамоне Федерико
    申请人:Фармиталиа Карло Эрба С.П.А. (Фирма)；
    IPC主号:
    专利说明:

     S
     The invention relates to a process for the preparation of 6-dowxy-anthrax pinglycosides of general formulas:
    i where P is hydrogen or hydroxyl G X is hydrogen,
    having antitumor shstiv-20
    1THING
    i The aim of the invention is to develop a method for producing new 6-deoxyanthracyclineglycosides derivatives having the same level of anti-tumor activity as the structural analogs of daunorubicin and doxorobicin, but having higher therapeutic indices than the latter. .thirty
    Example 1. 6-Deoxy-4-demethyl-dauporubicin (la), R — H, X — H,
    To a solution of 90 mg (0.24 mmol) of b-deoxycarmine-imidinone, synthesized in anhydrous dichloromethane, cooled to 5-10 ° C, was added, simultaneously with strong stirring, a solution of 2.4 mg (0.6 mmol ) 1-xnop-N-jO-ditrift-tercetyldaunosamine in diethyl ether and a solution of 154 mg 40
    (0.6 mmol) of silver trifluoromethanesulfonate in dichloromethane.
    After 5 minutes, another 0.3 mmol of haloaccharide and 0.3 mmol of silver trifluoromethanesulfonate were added. After 45 minutes, the reaction mixture was washed with collidine, filtered, washed with saturated aqueous sodium bicarbonate solution, water, dried and concentrated in vacuo. The resulting reddish oil is diluted with 100 ml of methanol and kept at room temperature for 24 hours to remove the 0-trifluoro-acetyl group. The crude g product obtained is purified by chromatography on a snickel using as eluent a mixture of methylene chloride with methiol and acetone in a volume of 0.
    five
    0
    0
    50
    50
    a nominal ratio of 20: 1: G, respectively, to produce an anthracycline ot-glycoside of formula (la) consisting of 7S: 9S and 7S: 9S isomers, having the following characteristics - isomer 75: 9S 20 mg, mp. 210-212 s, R. 0.27 at TLC on kieselgel plates (Merck F) using a mixture of methylene chloride and acetone as eluent in a volume ratio (4: 1), m / z 593 (), ntiP (2000 MHz, CDClg): inter alia S, 44 (doublet, 6 Hz, 3N, OH.j) - 2.42 (singlet, 3N, 2); 3.05-3.25 (two doublets Hz, H-10); 4.22 (singlet, .1И, OH-9); 5.01 (triplet, 6 Hz, 1H, H-7); 5.20 (triplet, 7 Hz, W, H-1); 6.66 (Binary doublet, Hz, .1H, III); 7.80 (singlet, 1H, H-6); 12, 62. (singlet, 1H, OH-4); 13.06 (singlet, W, OH-P).
    25 mg of isomer 7R: 9R with so pl. 174-178 ° C, R 0.23 at TLC on silica gel plates (Merck F254 using a mixture of methylene chloride C-acetone as an eluent in a volume ratio of 4: 1, t / g, 593 (M), ITMP (200 MHz, C1 CI ,,); inter alia & 1.44 (doublet, 5 Hz, 3N, OH-5); 2.41 (singlet, 3N, AHFS); 2.96 (doublet, Hz, 1H, H-lp axial); 3.30. (double doublet, 19 Hz, 1H, N – U equatorial); 4.25 (singlet, W, OH – 5); 5.07 (triplet, 3 Hz, 1H, H- 7); 5.27 (triplet, 8 Hz, 1H, H-1); 6.64 (binary doublet,,; | H, IN); 7.74 (singlet, 1H H-6); 12.60 (singlet, - 1H, OY-4); 13.10 (singlet, 1H, OH-P).
    By mild alkaline hydrolysis: the 7S: 9S islamer of formula (la) is removed by removing the H-trifluoroacetyl group to obtain the title compound in 98% quantitative yield, Bg 0.47 at TLC on silica gel plates using mixture as eluent methylene chloride-methanol-acetic acid-water in a volume ratio of 80: 20: 7: 3.
    PRI mme R 2. 6-Deoxy-4-demethyl-doxorubicin (1b), H - OHj X - N.
    The solution of 6-deoxy-4-demethyldau-rubicin, the synthesis of which is described in Example 1, is treated in a mixture of methanol and dioxane (Zrom to form 14-bromo-derivative. Effect on the resulting 14-bromo-aqueous aqueous solution of format-sodium at 3142
    at 100 ° C, 6-deoxy-4-demethyldoxorobigig with a mp. 167-1 70 ° C
    Rj.0.47 for those (Merck F) in the sytem of solvents CH Cl: MeOH: AcOH:: 1CO (8: 2: 0.7: 0.3 v / v).
    The cytotoxic activity of compounds (la) and (1b) was tested against HELa cells and P388 leukemia cells in experiments in vitro in comparison with daunorubicin and doxorubicin. In tab. Table 1 shows the results of testing inhibition of colony growth in vitro experiments. Table I

    Continuation of table 2
    one
    0.86
    7.5 10.00
    155 150 255
    The average life expectancy in percent compared to control,
    In tab. 3 shows the results of tests carried out in C H / Me groups with i.v. transplanted macroscopic leukemia and treated with i.v, tribute after transplantation of tumors. table 3
    3.1
    . 13.0
    20, 0
    0.78
    5.5 5.1
    11.2
    Dose giving a 50% reduction in cell number compared to untreated controls.
    Antitumor activity in the experiment.
    T. in vivo was studied in mice CDE-1 with ascitic leukemia P388; 10 cells per milliliter).
    Compounds were suspended in 10% Tween 80 and injected intraperitoneally. In tab. Figure 2 shows the antitumor activity against ascitic leukemia P388 (intraperitoneally treatment on day 1 after infection).
    table 2
    1a
    Daunorubicin

    225 183
    217,250
    215
    The average life expectancy compared with the control.
    In addition, compound 16 was tested for solid breast cancer, the results are presented in Table 4,
    Table 4

    0 in vivo treatment for 4 weeks,
    gg Suppression of tumor growth was evaluated for each group relative to its own control group, the weight of the tumor at the end of treatment (the weight of the tumor at the start of treatment was 100),
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    . The method of obtaining 6-deoxyanthracycline glycosides of general formula
    SNZK
    PTSS
    where R is hydrogen or hydroxyl;
    X is hydrogen,
    characterized in that. racemic 6-deoxyanthracycline formula
    Oh he
    it
    dissolved in dichloromethane, condensed at 5–10 ° C with 1-chloro-K, 0-di-trifluoroacetyldaunazamine at a molar ratio of 6-deoxyanthracycline of formula II and 1-chloro-G1,0-ditrifluoroacetylda-nazamine 1: 3.75 the presence of silver trifluoromethanesulfonate for 10 min with the formation of a mixture of 7S: 9S and 7R: 9R N, 0-trifopropacetyl derivatives of the corresponding deoxyanthracycline glycoside of general formula I, after which the O-trifluoroacetyl group is removed by treatment with methanol for 24 hours at room temperature , the resulting diastereomeric mixture of N-trifluoro cetyl deoksiantratsiklinglikozida derivative of general formula I is subjected hromatografiro- vaniyu on silica gel using as eluent a mixture of dichloromethane: methanol: acetone at a volume taken ies
    at a ratio of 20: 1: 1, 7S: 9S is isolated, derivatives of general formula 1, where B is N; X - trifluoroacetyl, which after mild alkaline hydrolysis turns into 7H: 9th glycoside of the general formula
    I, where R is H; X - H, if necessary, the obtained e -glyc (the 3d is treated with bromine in chloroform to obtain the corresponding 4-bromo derivatives, the subsequent hydrolysis of which
    with an aqueous solution of sodium formate at room temperature, they are converted into the corresponding -b-deoxyanthracycline-glycoside of the general 4-symulum I, where R is OH; X - I. ...
    类似技术:
    公开号 | 公开日 | 专利标题
    US4067969A|1978-01-10|Anthracycline glycosides, their preparation and use
    US4672057A|1987-06-09|Morpholino derivatives of daunorubicin and doxorubicin
    US4547567A|1985-10-15|Derivatives of 4&#39;-demethyl-4-epipodophyllotoxin
    SU1429935A3|1988-10-07|Method of producing 6 - deoxyanthracyclineglycosides
    US4325946A|1982-04-20|Anthracycline glycosides, their preparation, use and compositions thereof
    US4684629A|1987-08-04|3&#39;-deamino-3&#39;-hydroxy-4&#39;-deoxy-4&#39;-amino doxorubicin and related daunorubicin
    CA1157016A|1983-11-15|Anthracycline glycoside process
    US4891360A|1990-01-02|6-amino anthracyclines, process for their preparation and use thereof
    SU1590045A3|1990-08-30|Method of producing glycoside
    US4322412A|1982-03-30|Anthracycline glycosides, their preparation, use and compositions thereof
    HU217630B|2000-03-28|3`-aziridino-anthracycline derivatives, process for producing them and pharmaceutical compns. contg. them
    Mella et al.1988|1, 2-Dideoxy-3, 4: 5, 7-bis-o-|-d-gluco-and d-galacto-hept-1-ynitols: synthesis and conformat ional studies
    US4199571A|1980-04-22|Substituted anthracyclines, their preparation and use
    RU2073681C1|1997-02-20|Anthracycline glycoside and method of its synthesis
    FI78109B|1989-02-28|FOER FARING FOER FRAMSTAELLNING AV ANTRACYKLINGLYKOSIDER.
    JP3068258B2|2000-07-24|13-dihydro-3 &#39;-| anthracycline
    US5510469A|1996-04-23|2-acyloxy-4-morpholinyl anthracyclines
    RU2065863C1|1996-08-27|Deacetylcolchicine derivatives, process for preparation thereof, and antitumor composition
    AU2005304698A1|2006-05-18|Compositions and processes for preparing 13-deoxy-anthracyclines
    US4496485A|1985-01-29|Asymmetric 7-O-|-4-demethoxydaunomycinones
    SU1227117A3|1986-04-23|Method of producing anthracyclic glycosides or hydrochlorides thereof
    US4276289A|1981-06-30|Antitumor glycosides, their preparation and use
    DK170172B1|1995-06-06|Process for the preparation of 14-chloro-daunomycin or an acid addition salt thereof
    US4345086A|1982-08-17|Intermediate compounds in the preparation of spectinomycin
    US5412081A|1995-05-02|New 4&#39;-epi-4&#39;-amino anthracyclines
    同族专利:
    公开号 | 公开日
    AU6881887A|1987-05-14|
    BE899963A|1984-12-20|
    GR82130B|1984-12-13|
    AU574599B2|1988-07-07|
    IL72168D0|1984-10-31|
    SE8403353L|1984-12-24|
    FR2549046B1|1987-10-09|
    SU1561821A3|1990-04-30|
    CH661922A5|1987-08-31|
    DK37890A|1990-02-13|
    AT390252B|1990-04-10|
    CS243490B2|1986-06-12|
    DK37890D0|1990-02-13|
    GB8317037D0|1983-07-27|
    FI842505A|1984-12-24|
    IT1212101B|1989-11-08|
    JPH058179B2|1993-02-01|
    AU2952484A|1985-01-03|
    CS474084A2|1985-08-15|
    FR2549046A1|1985-01-18|
    US4939282A|1990-07-03|
    ZA844719B|1986-02-26|
    SE8901572D0|1989-05-02|
    CS243500B2|1986-06-12|
    AU561456B2|1987-05-07|
    ATA199684A|1989-09-15|
    HUT36136A|1985-08-28|
    NL8401957A|1985-01-16|
    IT8421522D0|1984-06-21|
    HU194902B|1988-03-28|
    SE8403353D0|1984-06-21|
    SE8901572L|1989-05-02|
    CH665422A5|1988-05-13|
    JPH0735392B2|1995-04-19|
    JPH0641179A|1994-02-15|
    CA1234104A|1988-03-15|
    DK306484D0|1984-06-22|
    DK306484A|1984-12-24|
    IL72168A|1988-07-31|
    JPS6013735A|1985-01-24|
    US5037970A|1991-08-06|
    HU196821B|1989-01-30|
    FI842505A0|1984-06-20|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3803124A|1968-04-12|1974-04-09|Farmaceutici It Soc|Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives|
    GB1467383A|1974-06-12|1977-03-16|Farmaceutici Italia|Daunomycin analogues|
    GB1509875A|1976-06-14|1978-05-04|Farmaceutici Italia|Optically active anthracyclinones and anthracycline glycosides|
    GB1567456A|1976-11-16|1980-05-14|Farmaceutici Italia|Daunomycin derivatives|
    GB1573036A|1977-05-05|1980-08-13|Farmaceutici Italia|Anthracyclines|
    GB1573037A|1977-05-05|1980-08-13|Farmaceutici Italia|Anthracyclines|
    GB1567457A|1977-11-11|1980-05-14|Farmaceutici Italia|Daunomycinone derivatives|
    US4370476A|1979-07-17|1983-01-25|Usher Thomas C|Dextran polycarboxylic acids, ferric hydroxide complexes|
    US4348388A|1980-04-02|1982-09-07|G.D. Searle & Co.|11-Amino-11-deoxydaunorubicin and analogs|
    US4374979A|1981-04-27|1983-02-22|The University Of Kansas Endowment Association|Regiospecific synthesis of anthracyclinone compounds such as daunomycinone|
    IT1210476B|1981-05-28|1989-09-14|Erba Farmitalia|ANTHRACYCLINES.|
    DE3361316D1|1982-03-02|1986-01-09|Sumitomo Chemical Co|Preparation of optically active 4-demethoxydaunomycinone|
    BE896743A|1982-08-13|1983-09-16|Erba Farmitalia|SYNTHESIS OF NAPHTACENEQUINONE.|
    GB8317037D0|1983-06-23|1983-07-27|Erba Farmitalia|6-deoxyanthracyclines|GB8317037D0|1983-06-23|1983-07-27|Erba Farmitalia|6-deoxyanthracyclines|
    GB2182926B|1985-11-19|1989-10-04|Erba Farmitalia|Nitro anthracyclines, process for their preparation and use thereof|
    GB8803301D0|1988-02-12|1988-03-09|Erba Carlo Spa|Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin|
    IT1275953B1|1995-03-22|1997-10-24|Sicor Spa|PROCEDURE FOR THE PREPARATION OF ANTIBIOTICS OF THE CLASS OF ANTHRACYCLINES|
    US5948896A|1997-08-13|1999-09-07|Gem Pharmaceuticals|Processes for preparing 13-deoxy anthracycline derivatives|
    US5942605A|1998-03-03|1999-08-24|Gem Pharmaceuticals, Inc.|5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them|
    JP4455643B2|2007-10-30|2010-04-21|東洋エンジニアリング株式会社|Granulating apparatus and granulating method using the same|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB838317037A|GB8317037D0|1983-06-23|1983-06-23|6-deoxyanthracyclines|
    [返回顶部]